SDCCQ vs. NMTR, SIENQ, TCBP, BDRX, BBLG, EVLO, VRAX, SPRC, NVTA, and SINT
Should you be buying SmileDirectClub stock or one of its competitors? The main competitors of SmileDirectClub include 9 Meters Biopharma (NMTR), Sientra (SIENQ), TC Biopharm (TCBP), Biodexa Pharmaceuticals (BDRX), Bone Biologics (BBLG), Evelo Biosciences (EVLO), Virax Biolabs Group (VRAX), SciSparc (SPRC), Invitae (NVTA), and Sintx Technologies (SINT). These companies are all part of the "medical" sector.
SmileDirectClub (NASDAQ:SDCCQ) and 9 Meters Biopharma (NASDAQ:NMTR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends.
9 Meters Biopharma has a consensus target price of $1.70, suggesting a potential upside of ∞. Given 9 Meters Biopharma's higher possible upside, analysts plainly believe 9 Meters Biopharma is more favorable than SmileDirectClub.
0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 22.3% of 9 Meters Biopharma shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by insiders. Comparatively, 2.4% of 9 Meters Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
SmileDirectClub's return on equity of 0.00% beat 9 Meters Biopharma's return on equity.
In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled 9 Meters Biopharma'saverage media sentiment score.
9 Meters Biopharma received 37 more outperform votes than SmileDirectClub when rated by MarketBeat users.
SmileDirectClub has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500. Comparatively, 9 Meters Biopharma has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500.
9 Meters Biopharma has lower revenue, but higher earnings than SmileDirectClub. SmileDirectClub is trading at a lower price-to-earnings ratio than 9 Meters Biopharma, indicating that it is currently the more affordable of the two stocks.
Summary
SmileDirectClub beats 9 Meters Biopharma on 7 of the 11 factors compared between the two stocks.
Get SmileDirectClub News Delivered to You Automatically
Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SDCCQ vs. The Competition
SmileDirectClub Competitors List
Related Companies and Tools
